Overall Score

Valuation Risk

Valuation remains elevated at 7.77x price-to-sales and 29.98x EV/EBITDA, leaving limited margin for error.

Price-to-book is 0.90x, which provides some asset-backed support despite the richer sales multiple.

Profitability Risk

Net margin is 10.6% and EBITDA margin is 31.3%, but operating margin is slightly negative at -0.9%, indicating mixed operating efficiency.

Returns remain weak, with ROIC near breakeven at -0.06% and ROE only 1.27%.

Cash Flow Risk

Free cash flow remains negative at -$25.7M TTM and free cash flow yield is -5.8%, highlighting ongoing cash burn.

Capex intensity is high at 67.2% of revenue and capex exceeds operating cash flow, pressuring cash generation.

Balance Sheet Risk

Liquidity is solid with a 2.92x current ratio and 2.06x quick ratio, supporting near-term obligations.

Leverage is manageable but not trivial, with net debt at 5.17x EBITDA and debt-to-equity at 0.20x.

Operational Risk

Working capital is positive at $20.9M and the cash conversion cycle is 45.6 days, suggesting moderate operating efficiency.

Inventory days are elevated at 71.9 days, which can create execution risk if demand softens.